Establishment and evaluation of a model for predicting 3-month mortality in Chinese patients with hepatic encephalopathy
- 19 Downloads
Hepatic encephalopathy (HE) is a serious complication of liver disease. To establish a model for predicting 3-month mortality in patients with HE in China. This retrospective study included 609 patients with HE admitted to the Peoples’ Hospital, Liaocheng City, China (August 2006 to January 2016). Patients were allocated to a modeling (n = 409) or validation (n = 200) group. Demographic/clinical characteristics, laboratory test results, Model for End Stage Liver Disease (MELD) score and Child-Turcotte-Pugh (CTP) score were extracted from medical records. A model for predicting death within 3 months after admission was established using logistic regression analysis (modeling group). Model validity (validation group) was assessed using receiver operating characteristic (ROC) curve analysis. 270/409(66.0%) patients died in the modeling group and 142/203(70.0%) died in the validation group. Compared with survivors, patients who died had more severe HE, and higher MELD score, CTP score, incidence of complications including hepatorenal syndrome (HRS) and upper gastrointestinal bleeding, and values for laboratory parameters including red blood cell count(RBC) and total bilirubin(TBIL)(P < 0.05). Regression analysis revealed RBC, TBIL, HE stage, HRS and upper gastrointestinal bleeding as independent factors associated with death (P < 0.05). The area under the ROC curve (AUC) for the model was 0.931.The model had a higher Youden index than MELD or CTP scores and predicted death in the validation group with a sensitivity of 83.1% and specificity of 93.4%. The established model has superior performance to MELD and CTP scores for predicting mortality in patients with HE.
KeywordsHepatic encephalopathy Mortality Prognosis MELD score Child-Turcotte-Pugh score
Compliance with ethical standards
Disclosure of potential conflicts of interest
The authors declare that they have no conflict of interest.
Research involving human participants
The study was approved by the ethics committee of the Peoples’ Hospital of Liaocheng City.
Due to the retrospective and anonymized design of the study, written consent from the participants was deemed not to be required.
- Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, Stravitz RT, Luketic V, Fuchs M, White MB, Bell DE, Gilles H, Morton K, Noble N, Puri P, Sanyal AJ (2011) The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 106:1646–1653. https://doi.org/10.1038/ajg.2011.157 CrossRefPubMedPubMedCentralGoogle Scholar
- Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R (2003) MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 52:134–139CrossRefGoogle Scholar
- Chinese Society of Gastroenterology, Chinese Society of Hepatology CMA, Chinese Medical Association (2013) Consensus on the diagnosis and treatment of hepatic encephalopathy. Zhonghua Gan Zang Bing Za Zhi 21:641–651Google Scholar
- Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998. Hepatology 35:716–721. https://doi.org/10.1053/jhep.2002.31250 CrossRefPubMedGoogle Scholar
- Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46:1853–1862. https://doi.org/10.1002/hep.21930 CrossRefPubMedPubMedCentralGoogle Scholar
- Jeong JH, Park IS, Kim DH, Kim SC, Kang C, Lee SH, Kim TY, Lee SB (2016) CLIF-SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis. Medicine (Baltimore) 95:e3935. https://doi.org/10.1097/md.0000000000003935 CrossRefGoogle Scholar
- Londono MC, Cardenas A, Guevara M, Quinto L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Gines P (2007) MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 56:1283–1290. https://doi.org/10.1136/gut.2006.102764 CrossRefPubMedPubMedCentralGoogle Scholar
- Samada Suarez M, Hernandez Perera JC, Ramos Robaina L, Barroso Marquez L, Gonzalez Rapado L, Cepero Valdes M, Hernandez Rivero H, Abdo Cuza A, Valdes AR, Perez Bernal J, Bernardos A (2008) Factors that predict survival in patients with cirrhosis considered for liver transplantation. Transplant Proc 40:2965–2967. https://doi.org/10.1016/j.transproceed.2008.08.110 CrossRefPubMedGoogle Scholar
- Simon-Talero M, Garcia-Martinez R, Torrens M, Augustin S, Gomez S, Pereira G, Guevara M, Gines P, Soriano G, Roman E, Sanchez-Delgado J, Ferrer R, Nieto JC, Sunye P, Fuentes I, Esteban R, Cordoba J (2013) Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol 59:1184–1192. https://doi.org/10.1016/j.jhep.2013.07.020 CrossRefPubMedGoogle Scholar
- Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P (2014) Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the liver. Hepatology 60:715–735. https://doi.org/10.1002/hep.27210 CrossRefPubMedGoogle Scholar
- Vlachogiannakos J, Kougioumtzian A, Triantos C, Viazis N, Sgouros S, Manolakopoulos S, Saveriadis A, Markoglou C, Economopoulos T, Karamanolis DG (2007) Clinical trial: the effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices. Aliment Pharmacol Ther 26:1479–1487. https://doi.org/10.1111/j.1365-2036.2007.03539.x CrossRefPubMedGoogle Scholar